Computer-Based Technologies for Virtual Screening and Analysis of Chemical Compounds Promising for Anti-HIV-1 Drug Design

被引:0
|
作者
Andrianov, A. M. [1 ]
Kashyn, I. A. [1 ,2 ]
Tuzikov, A. V. [2 ]
机构
[1] Inst Bioorgan Chem NASB, 5-2 Acad Kuprevich St, Minsk 220141, BELARUS
[2] United Inst Informat Problems NASB, 6 Surganov St, Minsk 220012, BELARUS
关键词
Virtual screening; Molecular docking; Molecular dynamics; Binding free energy calculations; HIV-1 entry inhibitors; Broadly neutralizing antibodies; NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; HIV-1; DISCOVERY; BROAD; INHIBITORS; GP120;
D O I
10.1007/978-3-319-54220-1_2
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Computer-based technologies for in silico drug development comprising virtual screening, high-throughput docking, molecular dynamics simulations, and binding free energy calculations are presented. The efficiency of these technologies is demonstrated by the identification of novel potential anti-HIV-1 agents able to mimic pharmacophoric properties of potent and broad neutralizing antibodies 10e8, VRC01, and 3074 that target three different functionally conserved regions of the viral envelope proteins.
引用
收藏
页码:14 / 23
页数:10
相关论文
共 50 条
  • [41] ANALYSIS OF STRUCTURAL CHARACTERISTICS OF CHEMICAL COMPOUNDS IN A LARGE COMPUTER-BASED FILE .3. STATISTICAL ASSOCIATION OF FRAGMENT INCIDENCE
    ADAMSON, GW
    LYNCH, MF
    LAMBOURN.DR
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1972, (19): : 2428 - &
  • [42] Computer-aided design of potential anti-HIV-1 non-nucleoside reverse transcriptase inhibitors by contraction of β-ring in TIBO derivatives
    Hemmateenejad, B
    Tabaei, SMH
    Namvaran, F
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2005, 732 (1-3): : 39 - 45
  • [43] Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity
    Curreli, Francesca
    Do Kwon, Young
    Zhang, Hongtao
    Scacalossi, Daniel
    Belov, Dmitry S.
    Tikhonov, Artur A.
    Andreev, Ivan A.
    Altieri, Andrea
    Kurkin, Alexander V.
    Kwong, Peter D.
    Debnath, Asim K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) : 6909 - 6927
  • [44] Design of Artificial C-Peptides as Potential Anti-HIV-1 Inhibitors Based on 6-HB Formation Mechanism
    Luo, Hui
    Zhao, Yan
    Ma, Yuheng
    Liang, Guodong
    Ga, Lu
    Meng, Zhao
    PROTEIN AND PEPTIDE LETTERS, 2024, 31 (06): : 447 - 457
  • [45] Non-nucleoside anti-HIV-1 reverse transcriptase inhibitors (NNRTIs): A chemical survey from lead compounds' to selected drugs for clinical trials
    Artico, M
    FARMACO, 1996, 51 (05): : 305 - 331
  • [46] Anti-HIV drug design based on a model of HIV-1 integrase complexed with viral DNA.
    Yang, Y
    Nicklaus, MC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U497 - U498
  • [47] Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites
    Alexander Berchanski
    Aviva Lapidot
    Journal of Molecular Modeling, 2009, 15 : 281 - 294
  • [48] Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites
    Berchanski, Alexander
    Lapidot, Aviva
    JOURNAL OF MOLECULAR MODELING, 2009, 15 (03) : 281 - 294
  • [49] KiBank:: A database for computer-aided drug design based on protein-chemical interaction analysis
    Aizawa, M
    Onodera, K
    Zhang, JW
    Amari, S
    Iwasawa, Y
    Nakano, T
    Nakata, K
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 (09): : 613 - 619
  • [50] Discovery of novel MSK1 inhibitors with hybrid virtual screening and structure-based drug design
    Huang, Zunnan
    Liu, Kangdong
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2011, 71